All In Biotech

Drug Trial Radar · NCT07023679

Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury

The Effect of Targeted Stellate Ganglion Morphine Infiltration on Reperfusion Injury in STEMI Patients After Primary PCI: A Multi-Center Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jul 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 2,588 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,588

Planned (sponsor's estimate)

Start

Jun 24, 2025

Primary completion

Jun 20, 2029

Study completion Jun 20, 2029

Sponsor

Lead sponsor
The Second Hospital of Anhui Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to investigate whether morphine modulates the functions of the stellate ganglion to reduce myocardial ischemia/reperfusion (I/R) injury in AMI patients. It will also assess the safety of injecting morphine around the stellate ganglion via ultrasound guidance. The main questions it aims to answer are: 1\. Does morphine regulate stellate ganglion function to reduce myocardial I/R injury in AMI patients and improve one year outcome in AMI patients? 3. What medical problems do participants experience when receiving injected morphine around the stellate ganglion? Researchers will compare morphine to a placebo saline (as a control group) to determine whether stellate ganglion infiltration with morphine effectively treats patients with AMI following primary PCI. Participants will: * Receive a single injection of morphine or saline around the stellate ganglion. * Evaluate the myocardial injury during their duration of hospital stay. * Record their symptoms and any major adverse cardiovascular and cerebrovascular events within one year post-surgery.

Conditions

  • Acute Myocardial Infarction (AMI)

Interventions

  • MorphineDrug

    Morphine (10 mg, 10 ml) is injected around the stellate ganglion using ultrasound guidance prior to coronary artery recanalization

  • saline placeboDrug

    Saline (10 ml) is injected around the stellate ganglion using ultrasound guidance prior to coronary artery recanalization

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of major adverse cardiovascular and cerebrovascular events (MACCE)Time frame: within one year post-surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, China · Recruiting

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.